Skip to main content
. 2024 Dec 30;4:280. doi: 10.1038/s43856-024-00718-1

Table 1.

The performance metrics of the GRS in the testing cohorts

Models OR per s.d. (95% CI), P AUC PRS threshold OR (95% CI), P Prevalence of HM
cvGRS 3.74 (3.19–4.44), 3.27 × 10–55 0.819 Top 20% versus other 80% 9.58 (6.43–14.68), 5.70 × 10–41 0.86
Top 10% versus other 90% 10.93 (5.92–22.05), 7.11 × 10–23 0.90
Top 5% versus other 95% 9.95 (4.24–28.50), 1.94 × 10–11 0.90
Top 2% versus other 98% 7.19 (2.13–37.86), 2.4 × 10−4 0.87
Top 1% versus other 99% 5.05 (1.07–47.61), 0.037 0.83
rvGRS 2.24 (1.99–2.54), 4.92 × 10–38 0.759 Top 20% versus other 80% 9.21 (6.21–14.04), 5.33 × 10–40 0.86
Top 10% versus other 90% 9.96 (5.50–19.54), 7.25 × 10–22 0.89
Top 5% versus other 95% 9.95 (4.24–28.50), 1.94 × 10–11 0.90
Top 2% versus other 980% 7.19 (2.13–37.86), 2.4 × 10–4 0.87
Top 1% versus other 99% 11.15 (1.61–480.32), 0.006 0.91
ExGRS 3.51 (3.05–4.07), 1.31 × 10−65 0.856 Top 20% versus other 80% 12.45 (8.07–19.86), 3.58 × 10-47 0.89
Top 10% versus other 90% 15.13 (7.59–34.31), 3.74 × 10−26 0.92
Top 5% versus other 95% 15.57 (5.70–59.48), 1.47 × 10–13 0.93
Top 2% versus other 980% 7.19 (2.13–37.86), 2.4 × 10–4 0.87
Top 1% versus other 99% 11.15 (1.61–480.32), 0.006 0.91